|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of General Surgery, University of Tuebingen, Tuebingen, Germany
2 Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom
* To whom correspondence should be addressed. E-mail: d.grundy{at}sheffield.ac.uk.
Bacterial translocation across the intestinal mucosal barrier leads to a macrophage
mediated inflammatory response, visceral hyperalgesia and ileus. Our aim was to
examine how mediators released into mesenteric lymph following lipopolysaccharide
(LPS) treatment influence intestinal afferent sensitivity and the role played by
prostanoids in any sensitization. Intestinal lymph was collected from awake rats
following treatment with either saline or LPS (5mg/kg, i.p.). Extracellular multiunit
afferent recordings were made from paravascular mesenteric nerve bundles supplying the
rat jejunum in vitro following arterial administration of control lymph, LPS lymph and
LPS. Mesenteric afferent discharge (AD) increased significantly after LPS lymph
compared to control lymph. Peak discharge occurred within 2 min and remained elevated
for 5 to 8 min. This response was attenuated by pre-treatment with naproxen (10µM), and
restored upon addition of prostaglandin E2 (5µM) in the presence of naproxen, but
AH6809 (5µM), a EP1/ EP2 receptors antagonist, failed to decrease the magnitude of LPS
lymph-induced response. LPS itself also stimulated mesenteric afferent discharge but was
unaffected by naproxen. TNF
was significantly increased in LPS lymph compared to
control lymph (1583 ± 197 vs 169 ± 38 pg/ml, P<0.01) but exogenous TNF
failed to
evoke any afferent nerve discharge. We concluded that, inflammatory mediators released
from the gut into mesenteric lymph during endotoxemia have a profound effect on
afferent discharge. These mediators influence afferent firing via the release of local
prostaglandins.
This article has been cited by other articles:
![]() |
N. Hamano, T. Inada, R. Iwata, T. Asai, and K. Shingu The {alpha}2-adrenergic receptor antagonist yohimbine improves endotoxin-induced inhibition of gastrointestinal motility in mice Br. J. Anaesth., April 1, 2007; 98(4): 484 - 490. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |